Follows adults with tuberculosis to study long-term lung health
Follows adults in treatment for, or treated for, tuberculosis to track lung health.
Key facts
- Who runs it
- Yonsei University
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
- Status
- Recruiting
- People taking part
- 360 people, planned
- Started
- 25 Feb 2025
- Expected to end
- 31 Dec 2031
- Type of study
- Observational
- Record updated
- 27 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are being treated for lung tuberculosis (TB), or who had treated lung TB in the past. It follows their lung health for five years.
- Age
- 19 years or older
- Sex
- All sexes can join
- Disease stage
- Tuberculosis of the lungs, either starting or going through treatment now, or treated in the past
- Earlier treatment
- People with lung TB can be starting or already on treatment, or have a history of treated lung TB
Main reasons for not taking part
- Younger than 19 years
- TB outside the lungs with no lung involvement
- Refusing to give informed consent
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age ≥19 years
- Diagnosed with pulmonary TB and either initiating or undergoing treatment or history of treated pulmonary TB
Who cannot take part
- Age <19 years
- Extrapulmonary TB without lung involvement
- Refusal to provide informed consent
Where in South Korea
- Department of Internal Medicine, Yonsei University College of Medicine Division of Pulmonology, Severance Hospital, Yonsei University Health SystemSeoul, South KoreaContact: Young Ae KangTaking people
About the trial
What the trial wants to find out
This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.
The group in the trial
- Active TB patients initiating or undergoing treatment or Post-treatment TB survivors
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
- Plain-language title
- Follows adults with tuberculosis to study long-term lung healthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Protocol of a Nationwide Observational Cohort Study for Long-Term Impacts on Lung Health and Life after Tuberculosis in Korea (LIFE-TB).Tuberculosis and respiratory diseases, 2026
- Record updated
- 27 April 2025